By Editor , 22 September 2026

Toronto – September 22, 2026 -- The United States Patent and Trademark Office has allowed BiomeRenewables Inc.'s Application No. 18/942094, covering the serration structure behind its FeatherEdge® wind turbine blade technology, the Canadian cleantech firm announced.

By Editor , 22 September 2026
No Stalking Horse Bidder for Cleveland's 925 Euclid Ave; Bids Due Oct. 24

Cleveland – September 22, 2026 -- Inglewood Associates and Gordon Brothers confirmed that the court-appointed Receiver overseeing the sale of 925 Euclid Avenue in Cleveland has not selected a stalking horse bidder, despite months of marketing the 1.45 million-square-foot historic tower.

By Editor , 22 September 2026

Victor, Montana – – September 21, 2026 -- Ridgeway Pharmacy, Ltd. has confirmed that a vulnerability in its vendor-supported website allowed an unauthorized third party to gain elevated access, potentially exposing patient names, dates of birth, addresses, prescription and health information, insurance details, and, for some individuals, payment card data.

By Editor , 22 September 2026
Google Backs Georgia Nuclear Uprates, Unlocking $900M Customer Savings

Atlanta – September 21, 2026 -- Georgia Power and Google have filed a new agreement with the Georgia Public Service Commission that ties Google's subscription to nuclear capacity uprates at Plants Hatch and Vogtle, a move projected to deliver approximately $900 million in customer benefits over the life of the units.

By Editor , 22 September 2026
Teamsters Back California Settlement on Paramount-WBD Merger

Washington – September 21, 2026 -- The Teamsters Union has endorsed a settlement agreement announced by California Attorney General Rob Bonta that clears a path for the pending merger between Paramount Skydance and Warner Bros. Discovery.

By Editor , 21 September 2026
FDA Clears IDE for Mercy's Ovarian Cancer Blood Test Trial

Waltham, Mass. – September 21, 2026 -- The U.S. Food and Drug Administration has approved Mercy BioAnalytics' Investigational Device Exemption application for its Evident Ovarian Cancer Screening Test, clearing the way for the company's pivotal SOARA Clinical Validation Study pending Institutional Review Board sign-off.

By Editor , 21 September 2026
Eastern Idaho Builders Face Multiple Permits Beyond Standard Building Approval

Idaho Falls – September 21, 2026 -- Construction projects in Eastern Idaho frequently require a stack of approvals beyond the standard building permit, including well permits, septic system reviews, driveway access clearances, utility connection permits, and floodplain reviews, according to insights from Ren Ferguson of Copper Creek Homes published by HelloNation.

By Editor , 21 September 2026
Scinai Regains Nasdaq Compliance on $1.00 Minimum Bid Price Rule

Jerusalem – September 21, 2026 -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) has regained compliance with Nasdaq's $1.00 minimum bid price rule after its American Depositary Shares closed at or above that threshold for 19 consecutive business days, Nasdaq Listing Qualifications confirmed in a September 18, 2026 letter.

By Editor , 21 September 2026
FDA Grants Priority Review to Insmed's ARIKAYCE Full Approval Bid

Bridgewater, N.J. – September 21, 2026 -- The U.S. Food and Drug Administration has accepted Insmed Incorporated's supplemental New Drug Application (sNDA) for full approval of ARIKAYCE (amikacin liposome inhalation suspension) to treat Mycobacterium avium complex (MAC) lung disease, granting Priority Review with a PDUFA target action date of January 28, 2027.